Name

LVVP

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for LVVP

Name

Alternate Names

Ambochlorin
CB-1348
Chlorambucilum
Chloraminophene
Chlorbutin
Chlorbutine
Chlorbutinum
Ecloril
Leukeran
Leukersan
Leukoran
Linfilizin
Linfolysin
WR-139013

Abbreviations

CHL
CLB

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

3088
003088

Primary Site

None

Histology

None

Remarks

A bifunctional alkylating antineoplastic agent. FDA approved uses on chronic lymphocytic leukemia, Hodgkins' and non-Hodgkin's lymphoma.

Coding

This drug should be coded

Name

Alternate Names

Alti-Prednisone
Alto-Pred
Ancortone
Apo-Prednisone
Colisone
Cortan
Dacortin
Delta-Dome#
Deltasone
Deltra
Fernisone Buffered
Keysone
Liquid Pred
Meticorten
Novo-Prednisone
Orasone
Panasol
Paracort#
Prednicen M
SK-Prednisone
Sterapred DS
Ultracorten
Winpred

Abbreviations

PDN
PRD
PRED

Category

Hormones and hormonal mechanisms

Subcategory

Glucocorticoid

NSC Number

10023
010023

Primary Site

Prednisone is used in regimens to treat multiple sites and histologies

Histology

None

Remarks

Code Prednisone when it is part of a drug regimen.

Do not code Prednisone when it is given to treat symptoms or as a single agent. In most cases when Prednisone is given by itself and not as part of a drug regimen, it does not affect the cancer and would not be coded as treatment.

Coding

Please see remarks for additional information

Name

Alternate Names

Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin

Abbreviations

LCR
VCR
VNCR

Category

Chemotherapy

Subcategory

Plant alkyloid--antimetabolite

NSC Number

067574
67574

Primary Site

None

Histology

None

Remarks

Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.

Coding

This drug should be coded

Name

Alternate Names

29060-LE
Alkaban
LE-29060
Velban
Velbe
Velsar
Vinblastine
Vinblastine sulfate

Abbreviations

VBL
VELB
VLB

Category

Chemotherapy

Subcategory

Plant alkaloid

NSC Number

049842
49842

Primary Site

None

Histology

None

Remarks

A cell cycle specific chemotherapeutic agent; vinca plant alkaloid; mitotic inhibitor. FDA approved uses in 3rd line breast cancer, choriocarcinoma, palliative in stages III and IV Hodgkin's lymphoma, Kaposi's sarcoma, mycosis fungoides, palliative in non-Hodgkin's histiocytic/lymphocytic lymphoma, and advanced testicular carcinoma.

Coding

This drug should be coded
Glossary